aluates Reports

$ 0.0

Automative

Lyophilized IVIG - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-24D11935

Global Lyophilized IVIG Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Lyophilized IVIG - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-24D11935

Report

September 2024

Pages:120

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Takeda

Grifols S A

CSL Limited

Octapharma AG

Biotest

Kedrion S p A

Hualan Bio

CNBG

Shanghai Raas

CBPO

LFB Group

BPL

Sichuan Yuanda Shuyang

Lyophilized IVIG - Market Size

The global market for Lyophilized IVIG was estimated to be worth US$ 145 million in 2023 and is forecast to a readjusted size of US$ 246.4 million by 2030 with a CAGR of 7.8% during the forecast period 2024-2030

Lyophilized IVIG - Market

Intravenous immunoglobulin (IVIG) contains the pooled immunoglobulin G (IgG) immunoglobulins from the plasma of approximately a thousand or more blood donors.

The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.Furthermore, the rising awareness about bleeding disorders and the availability of comprehensive treatment programs have contributed to increased diagnosis rates and access to coagulation factor therapies. Improved reimbursement policies and healthcare infrastructure have also played a role in expanding market reach.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lyophilized IVIG, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Lyophilized IVIG by region & country, by Type, and by Application.

The Lyophilized IVIG market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lyophilized IVIG.

Market Segmentation

Scope of Lyophilized IVIG - Market Report

Report Metric	Details
Report Name	Lyophilized IVIG - Market
Forecasted market size in 2030	US$ 246.4 million
CAGR	7.8%
Forecasted years	2024 - 2030
Segment by Type:	2.5g 1.25g
Segment by Application	Immunodeficiency Autoimmune Disease Acute Infection
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Lyophilized IVIG manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Lyophilized IVIG in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Lyophilized IVIG in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Lyophilized IVIG - Market size in 2030?

Ans: The Lyophilized IVIG - Market size in 2030 will be US$ 246.4 million.

Who are the main players in the Lyophilized IVIG - Market report?

Ans: The main players in the Lyophilized IVIG - Market are Takeda, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang

What are the Application segmentation covered in the Lyophilized IVIG - Market report?

Ans: The Applications covered in the Lyophilized IVIG - Market report are Immunodeficiency, Autoimmune Disease, Acute Infection

What are the Type segmentation covered in the Lyophilized IVIG - Market report?

Ans: The Types covered in the Lyophilized IVIG - Market report are 2.5g, 1.25g

Recommended Reports

Immunoglobulin Markets

Freeze Drying Solutions

Plasma & Coagulation

1 Market Overview

1.1 Lyophilized IVIG Product Introduction

1.2 Global Lyophilized IVIG Market Size Forecast

1.2.1 Global Lyophilized IVIG Sales Value (2019-2030)

1.2.2 Global Lyophilized IVIG Sales Volume (2019-2030)

1.2.3 Global Lyophilized IVIG Sales Price (2019-2030)

1.3 Lyophilized IVIG Market Trends & Drivers

1.3.1 Lyophilized IVIG Industry Trends

1.3.2 Lyophilized IVIG Market Drivers & Opportunity

1.3.3 Lyophilized IVIG Market Challenges

1.3.4 Lyophilized IVIG Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Lyophilized IVIG Players Revenue Ranking (2023)

2.2 Global Lyophilized IVIG Revenue by Company (2019-2024)

2.3 Global Lyophilized IVIG Players Sales Volume Ranking (2023)

2.4 Global Lyophilized IVIG Sales Volume by Company Players (2019-2024)

2.5 Global Lyophilized IVIG Average Price by Company (2019-2024)

2.6 Key Manufacturers Lyophilized IVIG Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Lyophilized IVIG Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Lyophilized IVIG

2.9 Lyophilized IVIG Market Competitive Analysis

2.9.1 Lyophilized IVIG Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Lyophilized IVIG Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lyophilized IVIG as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 2.5g

3.1.2 1.25g

3.2 Global Lyophilized IVIG Sales Value by Type

3.2.1 Global Lyophilized IVIG Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Lyophilized IVIG Sales Value, by Type (2019-2030)

3.2.3 Global Lyophilized IVIG Sales Value, by Type (%) (2019-2030)

3.3 Global Lyophilized IVIG Sales Volume by Type

3.3.1 Global Lyophilized IVIG Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Lyophilized IVIG Sales Volume, by Type (2019-2030)

3.3.3 Global Lyophilized IVIG Sales Volume, by Type (%) (2019-2030)

3.4 Global Lyophilized IVIG Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Immunodeficiency

4.1.2 Autoimmune Disease

4.1.3 Acute Infection

4.2 Global Lyophilized IVIG Sales Value by Application

4.2.1 Global Lyophilized IVIG Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Lyophilized IVIG Sales Value, by Application (2019-2030)

4.2.3 Global Lyophilized IVIG Sales Value, by Application (%) (2019-2030)

4.3 Global Lyophilized IVIG Sales Volume by Application

4.3.1 Global Lyophilized IVIG Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Lyophilized IVIG Sales Volume, by Application (2019-2030)

4.3.3 Global Lyophilized IVIG Sales Volume, by Application (%) (2019-2030)

4.4 Global Lyophilized IVIG Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Lyophilized IVIG Sales Value by Region

5.1.1 Global Lyophilized IVIG Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Lyophilized IVIG Sales Value by Region (2019-2024)

5.1.3 Global Lyophilized IVIG Sales Value by Region (2025-2030)

5.1.4 Global Lyophilized IVIG Sales Value by Region (%), (2019-2030)

5.2 Global Lyophilized IVIG Sales Volume by Region

5.2.1 Global Lyophilized IVIG Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Lyophilized IVIG Sales Volume by Region (2019-2024)

5.2.3 Global Lyophilized IVIG Sales Volume by Region (2025-2030)

5.2.4 Global Lyophilized IVIG Sales Volume by Region (%), (2019-2030)

5.3 Global Lyophilized IVIG Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Lyophilized IVIG Sales Value, 2019-2030

5.4.2 North America Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Lyophilized IVIG Sales Value, 2019-2030

5.5.2 Europe Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Lyophilized IVIG Sales Value, 2019-2030

5.6.2 Asia Pacific Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Lyophilized IVIG Sales Value, 2019-2030

5.7.2 South America Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Lyophilized IVIG Sales Value, 2019-2030

5.8.2 Middle East & Africa Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Lyophilized IVIG Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Lyophilized IVIG Sales Value

6.2.1 Key Countries/Regions Lyophilized IVIG Sales Value, 2019-2030

6.2.2 Key Countries/Regions Lyophilized IVIG Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Lyophilized IVIG Sales Value, 2019-2030

6.3.2 United States Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Lyophilized IVIG Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Lyophilized IVIG Sales Value, 2019-2030

6.4.2 Europe Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Lyophilized IVIG Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Lyophilized IVIG Sales Value, 2019-2030

6.5.2 China Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030

6.5.3 China Lyophilized IVIG Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Lyophilized IVIG Sales Value, 2019-2030

6.6.2 Japan Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Lyophilized IVIG Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Lyophilized IVIG Sales Value, 2019-2030

6.7.2 South Korea Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Lyophilized IVIG Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Lyophilized IVIG Sales Value, 2019-2030

6.8.2 Southeast Asia Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Lyophilized IVIG Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Lyophilized IVIG Sales Value, 2019-2030

6.9.2 India Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030

6.9.3 India Lyophilized IVIG Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Takeda

7.1.1 Takeda Company Information

7.1.2 Takeda Introduction and Business Overview

7.1.3 Takeda Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Takeda Lyophilized IVIG Product Offerings

7.1.5 Takeda Recent Development

7.2 Grifols

7.2.1 Grifols Company Information

7.2.2 Grifols Introduction and Business Overview

7.2.3 Grifols Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Grifols Lyophilized IVIG Product Offerings

7.2.5 Grifols Recent Development

7.3 CSL

7.3.1 CSL Company Information

7.3.2 CSL Introduction and Business Overview

7.3.3 CSL Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)

7.3.4 CSL Lyophilized IVIG Product Offerings

7.3.5 CSL Recent Development

7.4 Octapharma

7.4.1 Octapharma Company Information

7.4.2 Octapharma Introduction and Business Overview

7.4.3 Octapharma Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Octapharma Lyophilized IVIG Product Offerings

7.4.5 Octapharma Recent Development

7.5 Biotest

7.5.1 Biotest Company Information

7.5.2 Biotest Introduction and Business Overview

7.5.3 Biotest Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Biotest Lyophilized IVIG Product Offerings

7.5.5 Biotest Recent Development

7.6 Kedrion

7.6.1 Kedrion Company Information

7.6.2 Kedrion Introduction and Business Overview

7.6.3 Kedrion Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Kedrion Lyophilized IVIG Product Offerings

7.6.5 Kedrion Recent Development

7.7 Hualan Bio

7.7.1 Hualan Bio Company Information

7.7.2 Hualan Bio Introduction and Business Overview

7.7.3 Hualan Bio Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Hualan Bio Lyophilized IVIG Product Offerings

7.7.5 Hualan Bio Recent Development

7.8 CNBG

7.8.1 CNBG Company Information

7.8.2 CNBG Introduction and Business Overview

7.8.3 CNBG Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)

7.8.4 CNBG Lyophilized IVIG Product Offerings

7.8.5 CNBG Recent Development

7.9 Shanghai RAAS

7.9.1 Shanghai RAAS Company Information

7.9.2 Shanghai RAAS Introduction and Business Overview

7.9.3 Shanghai RAAS Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Shanghai RAAS Lyophilized IVIG Product Offerings

7.9.5 Shanghai RAAS Recent Development

7.10 CBPO

7.10.1 CBPO Company Information

7.10.2 CBPO Introduction and Business Overview

7.10.3 CBPO Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)

7.10.4 CBPO Lyophilized IVIG Product Offerings

7.10.5 CBPO Recent Development

7.11 LFB Group

7.11.1 LFB Group Company Information

7.11.2 LFB Group Introduction and Business Overview

7.11.3 LFB Group Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)

7.11.4 LFB Group Lyophilized IVIG Product Offerings

7.11.5 LFB Group Recent Development

7.12 BPL

7.12.1 BPL Company Information

7.12.2 BPL Introduction and Business Overview

7.12.3 BPL Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)

7.12.4 BPL Lyophilized IVIG Product Offerings

7.12.5 BPL Recent Development

7.13 Sichuan Yuanda Shuyang

7.13.1 Sichuan Yuanda Shuyang Company Information

7.13.2 Sichuan Yuanda Shuyang Introduction and Business Overview

7.13.3 Sichuan Yuanda Shuyang Lyophilized IVIG Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Sichuan Yuanda Shuyang Lyophilized IVIG Product Offerings

7.13.5 Sichuan Yuanda Shuyang Recent Development

8 Industry Chain Analysis

8.1 Lyophilized IVIG Industrial Chain

8.2 Lyophilized IVIG Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Lyophilized IVIG Sales Model

8.5.2 Sales Channel

8.5.3 Lyophilized IVIG Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Takeda

Grifols S A

CSL Limited

Octapharma AG

Biotest

Kedrion S p A

Hualan Bio

CNBG

Shanghai Raas

CBPO

LFB Group

BPL

Sichuan Yuanda Shuyang

List of Tables

Table 1. Lyophilized IVIG Market Trends

Table 2. Lyophilized IVIG Market Drivers & Opportunity

Table 3. Lyophilized IVIG Market Challenges

Table 4. Lyophilized IVIG Market Restraints

Table 5. Global Lyophilized IVIG Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Lyophilized IVIG Revenue Market Share by Company (2019-2024)

Table 7. Global Lyophilized IVIG Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Lyophilized IVIG Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Lyophilized IVIG Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Lyophilized IVIG Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Lyophilized IVIG Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Lyophilized IVIG

Table 13. Global Lyophilized IVIG Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lyophilized IVIG as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Lyophilized IVIG Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Lyophilized IVIG Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Lyophilized IVIG Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Lyophilized IVIG Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Lyophilized IVIG Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Lyophilized IVIG Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Lyophilized IVIG Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Lyophilized IVIG Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Lyophilized IVIG Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Lyophilized IVIG Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Lyophilized IVIG Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Lyophilized IVIG Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Lyophilized IVIG Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Lyophilized IVIG Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Lyophilized IVIG Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Lyophilized IVIG Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Lyophilized IVIG Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Lyophilized IVIG Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Lyophilized IVIG Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Lyophilized IVIG Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Lyophilized IVIG Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Lyophilized IVIG Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Lyophilized IVIG Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Lyophilized IVIG Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Lyophilized IVIG Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Lyophilized IVIG Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Lyophilized IVIG Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Lyophilized IVIG Sales Value by Region (2019-2024) & (%)

Table 44. Global Lyophilized IVIG Sales Value by Region (2025-2030) & (%)

Table 45. Global Lyophilized IVIG Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Lyophilized IVIG Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Lyophilized IVIG Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Lyophilized IVIG Sales Volume by Region (2019-2024) & (%)

Table 49. Global Lyophilized IVIG Sales Volume by Region (2025-2030) & (%)

Table 50. Global Lyophilized IVIG Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Lyophilized IVIG Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Lyophilized IVIG Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Lyophilized IVIG Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Lyophilized IVIG Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Lyophilized IVIG Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Lyophilized IVIG Sales Volume, (2025-2030) & (K Units)

Table 57. Takeda Company Information

Table 58. Takeda Introduction and Business Overview

Table 59. Takeda Lyophilized IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Takeda Lyophilized IVIG Product Offerings

Table 61. Takeda Recent Development

Table 62. Grifols Company Information

Table 63. Grifols Introduction and Business Overview

Table 64. Grifols Lyophilized IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Grifols Lyophilized IVIG Product Offerings

Table 66. Grifols Recent Development

Table 67. CSL Company Information

Table 68. CSL Introduction and Business Overview

Table 69. CSL Lyophilized IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. CSL Lyophilized IVIG Product Offerings

Table 71. CSL Recent Development

Table 72. Octapharma Company Information

Table 73. Octapharma Introduction and Business Overview

Table 74. Octapharma Lyophilized IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Octapharma Lyophilized IVIG Product Offerings

Table 76. Octapharma Recent Development

Table 77. Biotest Company Information

Table 78. Biotest Introduction and Business Overview

Table 79. Biotest Lyophilized IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Biotest Lyophilized IVIG Product Offerings

Table 81. Biotest Recent Development

Table 82. Kedrion Company Information

Table 83. Kedrion Introduction and Business Overview

Table 84. Kedrion Lyophilized IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Kedrion Lyophilized IVIG Product Offerings

Table 86. Kedrion Recent Development

Table 87. Hualan Bio Company Information

Table 88. Hualan Bio Introduction and Business Overview

Table 89. Hualan Bio Lyophilized IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Hualan Bio Lyophilized IVIG Product Offerings

Table 91. Hualan Bio Recent Development

Table 92. CNBG Company Information

Table 93. CNBG Introduction and Business Overview

Table 94. CNBG Lyophilized IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. CNBG Lyophilized IVIG Product Offerings

Table 96. CNBG Recent Development

Table 97. Shanghai RAAS Company Information

Table 98. Shanghai RAAS Introduction and Business Overview

Table 99. Shanghai RAAS Lyophilized IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Shanghai RAAS Lyophilized IVIG Product Offerings

Table 101. Shanghai RAAS Recent Development

Table 102. CBPO Company Information

Table 103. CBPO Introduction and Business Overview

Table 104. CBPO Lyophilized IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. CBPO Lyophilized IVIG Product Offerings

Table 106. CBPO Recent Development

Table 107. LFB Group Company Information

Table 108. LFB Group Introduction and Business Overview

Table 109. LFB Group Lyophilized IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 110. LFB Group Lyophilized IVIG Product Offerings

Table 111. LFB Group Recent Development

Table 112. BPL Company Information

Table 113. BPL Introduction and Business Overview

Table 114. BPL Lyophilized IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 115. BPL Lyophilized IVIG Product Offerings

Table 116. BPL Recent Development

Table 117. Sichuan Yuanda Shuyang Company Information

Table 118. Sichuan Yuanda Shuyang Introduction and Business Overview

Table 119. Sichuan Yuanda Shuyang Lyophilized IVIG Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 120. Sichuan Yuanda Shuyang Lyophilized IVIG Product Offerings

Table 121. Sichuan Yuanda Shuyang Recent Development

Table 122. Key Raw Materials Lists

Table 123. Raw Materials Key Suppliers Lists

Table 124. Lyophilized IVIG Downstream Customers

Table 125. Lyophilized IVIG Distributors List

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Lyophilized IVIG Product Picture

Figure 2. Global Lyophilized IVIG Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Lyophilized IVIG Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Lyophilized IVIG Sales Volume (2019-2030) & (K Units)

Figure 5. Global Lyophilized IVIG Sales Price (2019-2030) & (USD/Unit)

Figure 6. Lyophilized IVIG Report Years Considered

Figure 7. Global Lyophilized IVIG Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Lyophilized IVIG Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Lyophilized IVIG Revenue in 2023

Figure 10. Lyophilized IVIG Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. 2.5g Picture

Figure 12. 1.25g Picture

Figure 13. Global Lyophilized IVIG Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Lyophilized IVIG Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Lyophilized IVIG Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Lyophilized IVIG Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Lyophilized IVIG Price by Type (2019-2030) & (USD/Unit)

Figure 18. Product Picture of Immunodeficiency

Figure 19. Product Picture of Autoimmune Disease

Figure 20. Product Picture of Acute Infection

Figure 21. Global Lyophilized IVIG Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Lyophilized IVIG Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Lyophilized IVIG Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Lyophilized IVIG Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Lyophilized IVIG Price by Application (2019-2030) & (USD/Unit)

Figure 26. North America Lyophilized IVIG Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Lyophilized IVIG Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Lyophilized IVIG Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Lyophilized IVIG Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Lyophilized IVIG Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Lyophilized IVIG Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Lyophilized IVIG Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Lyophilized IVIG Sales Volume (%), (2019-2030)

Figure 38. United States Lyophilized IVIG Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Lyophilized IVIG Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Lyophilized IVIG Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Lyophilized IVIG Sales Value by Application (%), 2023 VS 2030

Figure 44. China Lyophilized IVIG Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030

Figure 46. China Lyophilized IVIG Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Lyophilized IVIG Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Lyophilized IVIG Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Lyophilized IVIG Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Lyophilized IVIG Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Lyophilized IVIG Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Lyophilized IVIG Sales Value by Application (%), 2023 VS 2030

Figure 56. India Lyophilized IVIG Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Lyophilized IVIG Sales Value by Type (%), 2023 VS 2030

Figure 58. India Lyophilized IVIG Sales Value by Application (%), 2023 VS 2030

Figure 59. Lyophilized IVIG Industrial Chain

Figure 60. Lyophilized IVIG Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

IVIg Liquid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Intravenous Immunoglobulin IVIg Market Research Report 2025

Intravenous Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lyophilized Human Immunoglobulin PH4 for Intravenous Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Immunoglobulin pH4 for Intravenous Injection Market Research Report 2024

Global Hyperimmune Globulin Product Market Research Report 2024

Global Intravenous Immune Globulin Therapies Market Research Report 2024

Human Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hyperimmune Globulin Injection Market Research Report 2024

Global Human Hyperimmune Globulins Market Research Report 2024

Global Intravenous Injection Immunoglobulin Market Research Report 2024

Global Lyophilized Beads for IVD Market Research Report 2024

Global Intravenous Immunoglobulin IVIg Therapy Market Research Report 2025

Global Human Immunoglobulin pH4 for Intravenous Injection COVID 19 Market Research Report 2024

Global IVD Lyophilized Reagent Market Research Report 2024

Human Plasma derived Hyperimmune Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Lyophilized Injectable Market Research Report 2024

Immunoglobulin Fusion Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions